7MM Parkinson’s disease pipeline focuses on disease-modifying agents | Healthcare Asia Magazine
, APAC
Photo from Envato

7MM Parkinson’s disease pipeline focuses on disease-modifying agents

There are a total of 93 products in Phase I-III development for PD treatment.

The Parkinson’s disease (PD) therapeutic landscape, which is heavily genericised, shows a growing focus on neuroprotective and disease-modifying therapies (DMTs) across the seven major markets (7MM), said GlobalData.

The report revealed that there are a total of 93 products in Phase I-III development within the 7MM for the treatment of PD, with 66% of these being prospective neuroprotective agents or DMTs.

These investigational agents aim to slow disease progression by targeting mechanisms like alpha-synuclein aggregation and neuroinflammation, said Lorraine Palmer, Pharma Analyst at GlobalData.

“26% of the pipeline DMTs in the pipeline target alpha-synuclein aggregation,” Palmer said.

Non-motor symptoms are also a key focus, with 18% of the pipeline classified as ‘other antiparkinsonian agents,’ which emphasises symptom management beyond the core motor symptoms.

“The distribution of the 93 pipeline agents in the 7MM underscores a strong emphasis on neuroprotective and disease-modifying treatments.” the analyst added.

*7MM countries- France, Germany, Italy, Spain, the UK, the US, and Japan.

Follow the link s for more news on

Join Healthcare Asia Magazine community
Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!